Acadia Pharmaceuticals Q2 EPS USD 0.18
ACAD•Q2 earnings and sales
Aug. 4 (Reuters) - Acadia Pharmaceuticals Q2 pretax profit USD 46.473 million.
- Q2 net income USD 31.5 million
- Q2 product sales USD 307.959 million
- Q2 operating expenses USD 270.123 million
Related News

Freshworks Q2 FY26 swings to GAAP profit of USD 3.2 million; revenue rises 16% year over year to USD 237.4 million
FRSH•

Voya Q2 FY26 net income drops to USD 90 million; after-tax adjusted operating earnings fall to USD 140 million
VOYA•


